Why Patients With Stage III NSCLC Should Be Treated With Curative Intent

Experts discuss treating unresectable Stage III NSCLC patients with curative intent. Oncologists discuss the difference between Stage III and Stage IV treatment goals.

Featuring:
Dr Mark Socinski
Dr Roy Decker
Dr Victoria Villaflor
Dr Jhanelle Gray
Dr Kristin Higgins
Dr Joe Chang
Victoria Sherry, NP
Mary Grizzard, NP

patient refusal,CRT toxicities/adverse events,esophagitis,educating patients,reassuring patients,patient education,CRT side effects,